Diligence memo · auto-generated · as of July 2, 2026

Acuity EyeCare Rollover II, LLC

Acuity EyeCare Rollover II, LLC looks under-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Acuity EyeCare Rollover II, LLC operates in Other Health Care, based in DALLAS.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Acuity EyeCare Rollover II, LLC has raised $9.8M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $6.8M on 2018-12-21.

Most recent recorded round closed around 2020-02-14.

Valuation (modeled)modeled

Provath models Acuity EyeCare Rollover II, LLC at approximately $61M (range $3.9M–$333M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.61× the median modeled value of Series A Other Health Care companies in 2019–2021 (164 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 7 months.

Last raise 6.4 yr ago; this sector typically re-raises about every 14 months.

Silent for over 3× the sector's normal cadence.

The last round was 1.5× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 75% of Other Health Care peers (5377 compared).

Modeled value ranks above 70% of those peers.

Closest niche peers: InvestCo Tabletop, LLC, Mediphore, Inc., iVinci Partners, LLC, Oklahoma Proton Center LLC, MicroOptx, Inc..

Peoplefiled

13 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.